Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.18B | 2.15B | 2.24B | 2.37B | 2.37B |
Gross Profit | 686.80M | 634.90M | 633.70M | 669.10M | 726.60M |
EBITDA | 243.80M | 230.70M | 237.00M | 268.80M | 325.90M |
Net Income | 156.80M | 166.60M | 149.20M | 172.70M | 230.90M |
Balance Sheet | |||||
Total Assets | 1.32B | 1.26B | 1.32B | 1.49B | 1.45B |
Cash, Cash Equivalents and Short-Term Investments | 335.60M | 322.10M | 198.50M | 195.80M | 343.80M |
Total Debt | 142.10M | 158.70M | 179.90M | 197.10M | 206.10M |
Total Liabilities | 674.80M | 617.10M | 683.70M | 807.90M | 714.50M |
Stockholders Equity | 644.40M | 645.20M | 634.70M | 678.80M | 731.10M |
Cash Flow | |||||
Free Cash Flow | 195.80M | 322.80M | 210.90M | 103.70M | 232.30M |
Operating Cash Flow | 225.30M | 355.20M | 238.80M | 139.60M | 280.30M |
Investing Cash Flow | -29.10M | -54.40M | -27.50M | -32.00M | -47.80M |
Financing Cash Flow | -188.30M | -171.10M | -191.20M | -249.80M | -155.70M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$7.10B | 22.40 | 78.00% | 4.71% | 14.08% | 15.81% | |
70 Outperform | HK$15.29B | 12.50 | 24.32% | 7.91% | 1.05% | -6.29% | |
63 Neutral | $45.82B | 19.63 | 9.39% | 0.60% | 30.73% | 90.08% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | HK$13.57B | 108.93 | 1.16% | ― | 3.21% | ― | |
55 Neutral | $49.40B | 43.26 | 5.20% | 0.74% | 12.10% | -44.33% | |
54 Neutral | $8.84B | ― | -10.70% | 0.20% | -13.99% | -32.74% |